Evotec
Tracked across 12 events · 557 articles · First seen Apr 01, 2026 · Last active Jun 12, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
NewsDesk Dashboard
Business
Impact: Evotec has nominated Dieter Weinand as the new Chairman of its Supervisory Board, aiming to strengthen commercial execution, strategic partnerships, and profitability. This move is part of Evotec's transformation into a more efficient and focused company.
Apr 07, 2026 · 9 articles
Business
Impact: Evotec appointed Dr. Ingrid Müller as its Chief Operating Officer, which is expected to strengthen its global operations and growth transformation.
Apr 15, 2026 · 7 articles
Business
Evotec>>> announced the appointment of Wang Rui>>> as Executive Vice President, Head of Global In Silico and AI on June 2, 2026. Wang Rui>>> brings over 20 years of experience in embedding scalable data, analytics,…
Impact: Evotec appointed Wang Rui>>> as Executive Vice President, Head of Global In Silico and AI, aiming to strengthen its AI-driven drug discovery and development capabilities. This appointment is expected to enhance Evotec>>>'s innovation and operational efficiency.
Jun 02, 2026 · 8 articles
Regulatory
Impact: Evotec SE is the issuer of the shares whose voting rights are being reported. The changes in holdings by Goldman Sachs>>> affect the ownership structure of Evotec>>>.
Apr 02, 2026 · 38 articles
Business
Evotec SE held its Annual General Meeting on June 11, 2026, where all agenda items were adopted by shareholders. Key outcomes included the election of Dieter Weinand and Dr. Wolfgang Hofmann to the Supervisory Board.…
Impact: Evotec held its Annual General Meeting, where shareholders adopted all agenda items and elected new members to its Supervisory Board, including a new Chairman. This event impacts Evotec's corporate governance and strategic direction.
Jun 11, 2026 · 7 articles
Accidents
A new Ebola outbreak, caused by the Bundibugyo strain, has emerged in the Democratic Republic of the Congo, primarily in Democratic Republic of the Congo — Ituri Province. The outbreak has resulted in over 220…
Impact: Evotec Biologics is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 446 articles
Tech
Lateral Pharma announced the publication of peer-reviewed research in PAIN (journal), identifying Lanthionine Synthetase C-Like Protein 1 (LanCL1) as a novel therapeutic target for neuropathic pain. This research demonstrates that Lateral Pharma's Stressed Cell Protectant…
Impact: Evotec was among the organizations whose researchers co-authored the publication.
Jun 11, 2026 · 10 articles
100
Evotec appointed Wang RuiEvotec appoints Rui Wang AI Head
100
Goldman Sachs changed voting rights EvotecGoldman Sachs adjusts Evotec stake
95
Evotec elected to Supervisory Board Dieter WeinandEvotec 2026 AGM Elects New Board
90
Evotec held Annual General MeetingEvotec 2026 AGM Elects New Board
85
Evotec nominated Wolfgang HofmannEvotec 2026 AGM Elects New Board
80
Evotec adopted agenda itemsEvotec 2026 AGM Elects New Board
70
Evotec re-elected to Supervisory Board Duncan McHaleEvotec 2026 AGM Elects New Board
70
Evotec re-elected to Supervisory Board Wesley WheelerEvotec 2026 AGM Elects New Board
Christian Wojczewski
ceo
↔
Evotec
Christian Wojczewski serves as the Chief Executive Officer of Evotec.
NEWSDESK
Track Evotec live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard